Expanded Sales Force Earns Pressure BioSciences, Inc. (PBIO) a “Speculative Strong Buy” Rating and Increased Sales
Dutton Associates recently rated Pressure BioSciences, Inc. (NASDAQ: PBIO) as a “Speculative Strong Buy,” pricing the 12-month target at $10…